DEA Schedule 1 drugs are substances the federal government has placed in the strictest tier of the Controlled Substances Act, meaning they are treated as having a high potential for abuse, no accepted medical use in the United States, and no established safety profile for use under medical supervision. Heroin, LSD, MDMA, psilocybin, and most forms of marijuana all sit on this list. A first-offense possession charge is a federal misdemeanor, but manufacturing or distributing these substances can trigger mandatory minimum sentences that reach 10 years or life depending on the quantity.
What Puts a Drug on Schedule I
Under 21 U.S.C. § 812(b)(1), a substance can only be placed in Schedule I if the government makes three findings at the same time: the drug has a high potential for abuse, it has no currently accepted medical use in treatment in the United States, and there is a lack of accepted safety for using it even under medical supervision.
All three prongs have to be satisfied together. A drug that is dangerous but has proven medical applications goes into a lower schedule, which is why fentanyl itself sits in Schedule II rather than Schedule I. The “no accepted medical use” requirement effectively locks out any substance that has not cleared the FDA’s approval process for at least one condition. The safety prong goes further: even if early studies showed promise, a substance stays in Schedule I if no one has established a safe dosage range for supervised use.
Substances Currently on Schedule I
The Schedule I list spans hundreds of compounds. The entries readers most often ask about include:
- Heroin
- LSD
- MDMA (commonly called ecstasy)
- Psilocybin (the active compound in certain mushrooms)
- Methaqualone
- Peyote
- Marijuana (with the exceptions described below)
Peyote carries a religious-use exception. Under 21 CFR § 1307.31, the Schedule I listing does not apply to the non-drug use of peyote in bona fide ceremonies of the Native American Church, and church members using peyote in that context are exempt from DEA registration. Anyone who manufactures or distributes peyote to the church still has to register with the DEA.
Marijuana’s Split Status After April 2026
Marijuana’s classification has changed, but only partly. On April 28, 2026, the Department of Justice issued a final rule moving two specific categories of marijuana into Schedule III: FDA-approved drug products containing marijuana, and marijuana handled under a state-issued medical marijuana license. Every other form of marijuana remains on Schedule I, and anyone possessing or distributing it outside those two channels still faces the same federal penalties as before.
The DOJ also opened an expedited administrative hearing, scheduled to begin June 29, 2026, to consider rescheduling all marijuana from Schedule I to Schedule III. That process has not concluded, so the partial rescheduling is the current federal law.
Designer Drugs and Fentanyl Analogues
The Schedule I list is longer than any published table because two mechanisms sweep in additional substances automatically.
The Federal Analogue Act, at 21 U.S.C. § 813, treats any substance “substantially similar” to a Schedule I or II drug as a Schedule I substance so long as it is intended for human consumption. Prosecutors use this to charge people over new chemical variations without waiting for the DEA to formally schedule each one.
Temporary emergency scheduling under 21 U.S.C. § 811(h) is the second mechanism. When the Attorney General finds that a substance poses an imminent hazard to public safety, the DEA can place it in Schedule I without completing the full analysis normally required. A temporary order lasts two years and can be extended by one more year while permanent scheduling proceedings run.
The most prominent use of this power has been the class-wide temporary scheduling of fentanyl-related substances. Rather than chasing each new analogue individually, the DEA placed the entire class in Schedule I through a temporary order, and Congress has extended that order repeatedly. Legislation to make the designation permanent has been introduced multiple times but, as of mid-2026, has not been enacted.
Federal Penalties for Possession
A first-offense conviction for simple possession of any controlled substance, including a Schedule I drug, is a federal misdemeanor. The maximum sentence is one year in prison, with a mandatory minimum fine of $1,000.
Penalties escalate quickly with prior drug convictions:
- After one prior drug conviction: 15 days to 2 years in prison and a minimum $2,500 fine.
- After two or more prior drug convictions: 90 days to 3 years and a minimum $5,000 fine.
These enhancements can be triggered by prior state drug convictions, not just federal ones.
Federal Penalties for Manufacturing and Trafficking
Penalties for making or distributing Schedule I substances are built around quantity thresholds. Crossing a threshold activates a mandatory minimum sentence that judges generally cannot go below.
Heroin illustrates the three tiers Congress set:
- Below the quantity thresholds: up to 20 years in prison and a fine up to $1 million for an individual. If death or serious bodily injury results from the drug’s use, the mandatory minimum jumps to 20 years.
- 100 grams or more: a mandatory minimum of 5 years and a maximum of 40 years, with fines up to $5 million for an individual. Death or serious bodily injury raises the mandatory minimum to 20 years.
- 1 kilogram or more: a mandatory minimum of 10 years up to life, with fines up to $10 million for an individual. Death or serious bodily injury raises the mandatory minimum to a range of 20 years to life.
Prior felony drug convictions roughly double these ranges. A defendant with one prior felony drug conviction charged at the 1-kilogram threshold, for example, faces a mandatory minimum of 20 years rather than 10. Similar quantity-based tiers exist for other Schedule I and II substances, including LSD, marijuana, and methamphetamine, each with its own weight triggers.
The Safety Valve
Federal law provides one narrow route around a mandatory minimum for a drug offense. Under 18 U.S.C. § 3553(f), a judge can sentence below the statutory floor if the defendant meets all five of these conditions:
- Limited criminal history: no more than 4 criminal history points (excluding 1-point offenses), no prior 3-point offense, and no prior 2-point violent offense under the sentencing guidelines.
- No violence or weapons: the defendant did not use violence, make credible threats, or possess a firearm in connection with the offense.
- No death or serious injury resulting from the offense.
- Not a supervisor, manager, leader, or organizer of others in the offense, and not part of a continuing criminal enterprise.
- Truthful, full cooperation with the government about the offense before sentencing.
The safety valve does not eliminate punishment. It lets the judge use the sentencing guidelines instead of the statutory minimum. Every criterion has to be met.
Consequences Beyond Prison
A federal drug conviction reaches into housing, work, immigration status, and civil rights.
Federal law includes a mandatory ban on public housing for people with certain drug convictions and gives local housing authorities discretion to deny housing based on any criminal activity. A felony drug conviction bars firearm possession under 18 U.S.C. § 922(g)(1), which prohibits anyone convicted of a crime punishable by more than one year in prison from owning or possessing a gun. Separately, anyone who is an unlawful user of or addicted to a controlled substance is barred from firearm possession regardless of whether they have been convicted of anything.
For non-citizens, a drug conviction can trigger deportation or make someone inadmissible. Professional licensing boards in many fields treat drug convictions as disqualifying, and certain federal employers are prohibited from hiring people with felony drug records. In a majority of states, a felony drug conviction also triggers a lifetime ban on receiving certain public assistance benefits, though many states have opted out of or modified that restriction.
Federal student financial aid is the one area that has moved in the opposite direction. Congress eliminated the drug-conviction restriction starting with the 2021–22 award year, so students with drug convictions are no longer automatically disqualified from federal grants, loans, or work-study.
How Substances Come Off Schedule I
The list can change. Any interested person can petition the DEA to reschedule, deschedule, or add a substance under 21 CFR § 1308.43. The petition triggers a scientific and medical review by the Department of Health and Human Services and a formal analysis by the DEA. If HHS concludes a substance should not be controlled at all, that recommendation is binding on the DEA; otherwise, the DEA makes the final scheduling decision.
The process is slow. The marijuana rescheduling effort that began in 2023 was still in administrative hearings as of mid-2026, and only two narrow categories of marijuana products had actually moved to Schedule III by then. A move down the schedule changes the legal picture significantly: doctors with a standard DEA registration can prescribe a Schedule III drug, research protocols face fewer barriers, and criminal penalties for violations are lower than they are for Schedule I.